Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Blood

• Publication date

  1990-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V75.6.1346.1346PMID 2310831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International System for Human Cytogenetic Nomenclature

  2020cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia

  1992influential reference
• T‐CELL DEPLETION OF HUMAN BONE MARROW

  1989cited by this paper
• Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse.

  1989cited by this paper
• T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads.

  1989cited by this paper
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms.

  1989cited by this paper
• Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.

  1988cited by this paper
• Cytogenetic studies on acute nonlymphocytic leukemia in relapse.

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988influential reference
• Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation.

  1988cited by this paper
• Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase.

  1988cited by this paper
• T CELL DEPLETION WITH CAMPATH‐1 IN ALLOGENEIC BONE MARROW TRANSPLANTATION

  1988cited by this paper
• Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies.

  1987cited by this paper
• Cytogenetic evidence of partial chimerism after T cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients.

  1987cited by this paper
• Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning.

  1987cited by this paper
• Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms.

  1987cited by this paper
• The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants

  1986cited by this paper
• High resolution banding of chronic myeloid leukemia chromosomes.

  1986cited by this paper
• Human chromosome variation: the discriminatory power of Q-band heteromorphism (variant) analysis in distinguishing between individuals, with specific application to cases of questionable paternity.

  1986cited by this paper
• Soybean Lectin Agglutination and E-Rosette Depletion for Removal of T-Cells from HLA-Identical Marrow Grafts: Results in 60 Consecutive Patients Transplanted for Hematologic Malignancy

  1986cited by this paper
• Ph1 negative haematological chimaerism after marrow transplantation in Ph1 positive chronic granulocytic leukaemia

  1986cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites.

  1985cited by this paper
• QUANTITATION OF T LYMPHOCYTES IN HUMAN BONE MARROW BY A LIMITING DILUTION ASSAY

  1985cited by this paper
• Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation

  1985cited by this paper
• Allogeneic Bone‐Marrow Transplantation

  1983cited by this paper
• Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia.

  1982cited by this paper
• Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

  1981cited by this paper
• Spontaneous and induced changes in cell populations in heavily irradiated mice.

  1959cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The mythological chimera and new era of relapse prediction post-transplant.

  2022cites this paper
• A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.

  2021cites this paper
• Chimerism Testing in Allogeneic Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.

  2016cites this paper
• Chronic myeloid leukemia

  2015cites this paper
• Translocation t(1;3)(p36;p21) and other aberrations in a case of AML secondary to MDS

  2014cites this paper
• New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461

  2013cites this paper
• t(1;3)(p36;p21) as the Sole Clonal Abnormality in Refractory Acute Myeloid Leukemia

  2012cites this paper
• Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats

  2011cites this paper
• Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

  2010cites this paper
• NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods,

  2010cites this paper
• Hochpolymorphe molekulargenetische Marker in der Transplantationsimmunologie,Anthropologie und Forensik

  2008cites this paper
• Cytogenetic evolution patterns in CML post-SCT

  2007cites this paper
• Simultaneous regression of Philadelphia chromosome and multiple nonrecurrent clonal chromosomal abnormalities with imatinib mesylate in a patient autografted 22 years before for chronic myelogenous leukemia

  2007cites this paper
• A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients

  2006cites this paper
• Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

  2005cites this paper
• Inv(1)(p22q25) in chronic myeloproliferative disease: constitutional or clonal defect?

  2005cites this paper
• Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL

  2005cites this paper
• Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.

  2005cites this paper
• How and when should we monitor chimerism after allogeneic stem cell transplantation?

  2005cites this paper
• Fanconi Anemia: Contribution of Molecular Analyses to the Identification of Bone Marrow Graft Donors and the Study of Chimerism in Grafted Patients

  2004cites this paper
• Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

  2004cites this paper
• Estudio secuencial y cuantitativo del quimerismo hemopoyético en pacientes sometidos a un trasplante alogénico de progenitores hemopoyéticos con depleción linfoide T o con acondicionamiento sub-mieloablativo.

  2004cites this paper
• CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation

  2004cites this paper
• Use of ApoB' hyper variable region in studying mixed chimerism and maternal contamination in North Indian populations.

  2004cites this paper
• T-Cell Depletion to Prevent Graft-vs-Host Disease

  2004cites this paper
• of different hematologic lineages before and after relapse leukemia transplanted with T-cell-depleted bone marrow : involvement Characterization of mixed chimerism in patients with chronic myeloid

  2003cites this paper
• The Occurrence of Philadelphia Chromosome (Ph) Negative Leukemia after Hematopoietic Stem Cell Transplantation for Ph Positive Chronic Myeloid Leukemia: Implications for Disease Monitoring and Treatment

  2003cites this paper
• leukemia without clinical relapse : a study of 64 patients chain reaction after marrow transplant for chronic myelogenous

  2003cites this paper
• Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation.

  2003cites this paper
• Mixed Chimerism of Bone Marrow Vessels (Endothelial Cells, Myofibroblasts) Following Allogeneic Transplantation for Chronic Myelogenous Leukemia

  2003cites this paper
• Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation

  2002cites this paper
• Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.

  2002cites this paper
• Mixed chimerism of bone marrow CD34+ progenitor cells (genotyping, bcr/abl analysis) after allogeneic transplantation for chronic myelogenous leukemia1

  2002cites this paper
• Cytogenetics of chronic myeloid leukaemia.

  2001cites this paper
• Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.

  2001cites this paper
• Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation

  2001cites this paper
• The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

  2001cites this paper
• From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.

  2000cites this paper
• Effects of Mixed Chimerism and Immune Modulation on GVHD, Disease Recurrence and Survival after HLA-identical Marrow Transplantation for Hematologic Malignancies

  2000cites this paper
• Innovative approaches for allogeneic blood and marrow transplantation for treatment of hematological malignancies: Graft engineering and nonmyeloablative preparative regimens

  2000cites this paper
• Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.

  2000cites this paper
• Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T‐cell‐depleted bone marrow transplantation and after donor leucocyte infusion

  2000cites this paper
• Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.

  2000cites this paper
• Non‐random involvement of chromosome 13 in patients with persistent or relapsed disease after bone‐marrow transplantation for chronic myeloid leukemia

  2000cites this paper
• Characterization of lineage‐specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

  2000cites this paper
• Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM)

  2000cites this paper
• Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.

  2000cites this paper
• Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants

  1999cites this paper
• Treatment-related chronic myelogenous leukemia

  1999cites this paper
• Graft‐vs.‐malignancy with allogeneic blood stem cell transplantation: A potential primary treatment modality

  1999cites this paper
• Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse

  1999cites this paper
• [Bone marrow transplantation in chronic myeloid leukemia].

  1999cites this paper
• Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.

  1999cites this paper
• Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

  1998cites this paper
• Usefulness of detection of minimal residual disease by ‘hypermetaphase’ fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia

  1997cites this paper
• Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.

  1997cites this paper
• Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia

  1997cites this paper
• Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

  1997cites this paper
• Minimal Residual Disease Post‐Bone Marrow Transplantation for Hemato‐Oncological Diseases

  1996cites this paper
• Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.

  1996cites this paper
• Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences.

  1996cites this paper
• Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.

  1996cites this paper
• Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.

  1996cites this paper
• Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect?

  1996cites this paper
• Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.

  1996cites this paper
• Interleukin-1 production following T-cell-depleted and unmodified marrow grafts.

  1996cites this paper
• Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT.

  1996cites this paper
• Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.

  1995cites this paper
• Graft Versus Host Disease with Mixed Chimerism

  1995cites this paper
• The role of the lymphocyte in an immune response.

  1995cites this paper
• Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era.

  1995cites this paper
• Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle.

  1995cites this paper
• Novel cellular therapies.

  1995cites this paper
• Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.

  1994cites this paper
• Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.

  1994cites this paper
• Mononuclear cell adoptive immunotherapy.

  1994cites this paper
• Leukemia: management of relapse after allogeneic bone marrow transplantation.

  1994cites this paper
• Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.

  1994cites this paper
• Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse.

  1994cites this paper
• Transplantation, Chemical Inheritance, and the Identity of Organs

  1994cites this paper
• Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease

  1994cites this paper
• Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques.

  1993cites this paper
• Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.

  1993cites this paper
• Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients

  1993cites this paper
• Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.

  1993cites this paper
• T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-Leukemia

  1993cites this paper
• Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.

  1993cites this paper
• Is there any future for T-cell depleted bone marrow transplantation in chronic myeloid leukaemia?

  1993cites this paper
• What does one do for the CML patient in relapse after allogeneic bone marrow transplantation?

  1993cites this paper
• Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group

  1993cites this paper
• Hematopoietic recovery from host progenitors with normal karyotype devoid of Philadelphia chromosome in a patient with CML after allogeneic BMT.

  1993cites this paper
• Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

  1993cites this paper
• Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.

  1993cites this paper
• Mixed chimaerism; detection and significance following BMT.

  1993cites this paper
• Demonstration of chimerism after allogeneic bone marrow transplantation by polymerase chain reaction of Y-chromosome-specific nucleotide sequences--characterization of a new technical approach.

  1993cites this paper
• Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

  1993cites this paper
• Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse.

  1993cites this paper
• Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans

  1993cites this paper
• Bone Marrow Transplantation: A Review

  1993cites this paper